Document Type
Report
Publication Date
6-4-2024
Abstract
We report a case of hairy tongue that developed in a young Caucasian
woman during systemic baricitinib therapy for severe alopecia areata.
Because she experienced good clinical regrowth of her hair during
treatment, she did not want to interrupt therapy. We recommended she
use a toothbrush to debride her tongue on a daily basis, which was
successful. Hairy tongue most commonly occurs in elderly, debilitated
males with poor oral hygiene. It is thought to occur because of overgrowth
of chromogenic bacteria and/or yeast on the tongue. This unusual side
effect during baricitinib therapy suggests that immune suppression may
play a role. Clinicians should be aware of hairy tongue development
during baracitinib therapy.
Recommended Citation
Gaspari, Anthony, "Hairy Tongue Associated With the Use of Baricitinib Therapy for Ophiasis Pattern Alopecia Areata" (2024). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 196.
https://jdc.jefferson.edu/dcbfp/196
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Language
English
Included in
Chemical Actions and Uses Commons, Dermatology Commons, Skin and Connective Tissue Diseases Commons, Stomatognathic Diseases Commons
Comments
This article is the author's final published version in [journal], Volume 3, Issue 2, June 2024, Pages 699 - 701.
The published version is available at https://doi/org/10.1002/jvc2.348.
Copyright © 2023 The Authors